Overview

Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Patients will be recruited from those who will undergo contrast enhanced MRI. Safety and tolerability will be assessed.
Details
Lead Sponsor:
Bayer